---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-016422"
form_type: "8-K"
ticker: "ELMD"
cik: "0001488917"
company_name: "Electromed, Inc."
filed_at: "2026-05-12T20:06:45+00:00"
generated_at: "2026-05-12T21:28:27.496980+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Electromed posts record Q3 FY2026 revenue $18.6M (+18% YoY); EPS $0.35 (+59%)

## Summary
- Net revenue $18.6M (+18.4% YoY); homecare revenue $16.7M (+18.6%) driven by 57 direct sales reps.
- Operating income $3.8M (+76.0% YoY, 20.3% of revenue); net income $3.0M, $0.35 diluted EPS.
- Cash $17.0M, no debt; working capital $40.0M; shareholders' equity $49.2M.
- 14th consecutive quarter of YoY revenue and profit growth; 86% of covered lives under contract.

## SEC filing metadata
- accession: 0001437749-26-016422
- form_type: 8-K
- ticker: ELMD
- cik: 0001488917
- company_name: Electromed, Inc.
- filed_at: 2026-05-12T20:06:45+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1488917/000143774926016422/0001437749-26-016422-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1488917/000143774926016422/elmd20260213_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-016422
- JSON: https://secwatch.observer/filing/0001437749-26-016422.json
- Plain text: https://secwatch.observer/filing/0001437749-26-016422.txt

## Key facts
- Earnings Releases
  Electromed, Inc. reported the three months ended March 31, 2026 results: revenue $ 18.6 million, net income $ 3.0 million, or $ 0.35 per diluted share, EPS $ 0.35 per diluted share.
  - Period: the three months ended March 31, 2026
  - Revenue: $ 18.6 million
  - Net income: $ 3.0 million, or $ 0.35 per diluted share
  - EPS: $ 0.35 per diluted share
  - Result: reported results
  source text: today announced financial results for the three and nine months ended March 31, 2026 (“ Q3 FY 2026 ”). Q3 FY 2026 Company Highlights ● Net revenues increased 18.4% to a record $ 18.6 million in Q3 FY 2026, from $ 15.7 million in the third quarter of the prior fiscal year, led by an 18.6% increase in the core homecare market. ● Operating income increased to a record $
  evidence_url: https://www.sec.gov/Archives/edgar/data/1488917/000143774926016422/0001437749-26-016422-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.